The ROE as of December 2025 (TTM) for China Regenerative Medicine International Limited (8158.HK) is 20.39%

According to China Regenerative Medicine International Limited’s latest financial reports and current stock price. The company's current ROE is 20.39%. This represents a change of 317.80% compared to the average of 4.88% of the last 4 quarters.

China Regenerative Medicine International Limited (8158.HK) Historical ROE (quarterly & annually)

How has 8158.HK ROE performed in the past?

The mean historical ROE of China Regenerative Medicine International Limited over the last ten years is -214.26%. The current 20.39% ROE has changed -109.52% with respect to the historical average. Over the past ten years (40 quarters), 8158.HK's ROE was at its highest in in the March 2024 quarter at 33.48%. The ROE was at its lowest in in the December 2023 quarter at -969.86%.

China Regenerative Medicine International Limited (8158.HK) ROE by Quarter and Year

Discovering the peaks and valleys of China Regenerative Medicine International Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

China Regenerative Medicine International Limited (8158.HK) Average ROE

How has 8158.HK ROE performed in the past?

The current ROE of China Regenerative Medicine International Limited (8158.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

China Regenerative Medicine International Limited (8158.HK) ROE vs. Peers

How is 8158.HK’s ROE compared to its peers?

China Regenerative Medicine International Limited’s ROE is greater than PuraPharm Corporation Limited (-36.23%), less than Regent Pacific Group Limited (80.95%), greater than China Health Group Inc. (-17.63%), greater than King International Investment Limited (-19.28%), greater than Kelfred Holdings Limited (-9.01%), greater than Good Fellow Healthcare Holdings Limited (-732.70%), less than Universal Health International Group Holding Limited (3.85%), less than Bamboos Health Care Holdings Limited (7.76%), less than Extrawell Pharmaceutical Holdings Limited (17.46%), less than China Healthwise Holdings Limited (57.72%),

Build a custom stock screener for China Regenerative Medicine International Limited (8158.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like China Regenerative Medicine International Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

China Regenerative Medicine International Limited (8158.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like China Regenerative Medicine International Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.